Rovensa Next secures $8.8M FINEP loan for Brazil biosolutions R&D

What's the deal? Rovensa Next has secured R$45 million (approximately $8.8 million) in debt financing from the Brazilian Funding Authority for Studies and Projects (FINEP)Dealroom has a profile for this one. Try Dealroom → to fund research, development, and innovation in Brazil. The company develops biosolutions for agriculture and markets its products in more than 90 countries.

Where the money goes: The funds will back new bionutrition, biocontrol, and adjuvant inputs, strengthening Rovensa Next's portfolio. The financing came through FINEP's "Mais Inovação" (More Innovation) program, a subsidised initiative to promote research and technological development.

The terms: The FINEP transaction runs over a 16-year term and covers 90% of the total project cost. That long horizon gives the company stability to advance its research pipeline.

Why Brazil? Brazil is a growing hub for Rovensa Next's global R&D operations. The company recently opened a pilot fermentation plant at its Monte Mor industrial site, working alongside its Global Research and Innovation Center for Biosolutions in Hortolândia to scale microbial biosolutions from lab to industrial production.

What they're saying: "Brazil is a priority market and a strategic powerhouse for our global innovation network," said Victor Sonzogno, head of Brazil at Rovensa Next. He added that the funding is "a major recognition of the strength of our innovation program and the potential of the technologies we are developing in Brazil."

The signal: State-backed lending like FINEP's is emerging as a key lever for agricultural innovation in Brazil, one of the world's most biologically diverse and advanced farming markets. For Rovensa Next, the deal ties local research capacity to a broader push to scale biosolutions for growers worldwide.

Read more: agribusinessglobal.com

Image credit: Generated with Gemini